Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $6.81 Million - $7.9 Million
-85,100 Reduced 94.87%
4,600 $423,000
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $6.42 Million - $7.86 Million
85,000 Added 1808.51%
89,700 $8.14 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $350,667 - $410,122
4,700 New
4,700 $357,000
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $4.03 Million - $4.69 Million
-49,300 Reduced 95.36%
2,400 $196,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $2.4 Million - $2.65 Million
-28,100 Reduced 35.21%
51,700 $4.72 Million
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $4.23 Million - $4.99 Million
-50,700 Reduced 38.85%
79,800 $6.82 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $9.74 Million - $11.8 Million
124,700 Added 2150.0%
130,500 $12.3 Million
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $9.68 Million - $10.7 Million
-117,900 Reduced 95.31%
5,800 $504,000
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $7.19 Million - $8.09 Million
88,800 Added 254.44%
123,700 $10.8 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $826,839 - $1.16 Million
11,700 Added 50.43%
34,900 $2.88 Million
Q4 2019

Feb 13, 2020

SELL
$84.35 - $95.37 $8.48 Million - $9.59 Million
-100,551 Reduced 81.25%
23,200 $2.2 Million
Q3 2019

Nov 08, 2019

BUY
$85.54 - $94.26 $3.9 Million - $4.3 Million
45,651 Added 58.45%
123,751 $10.8 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $1.92 Million - $2.37 Million
25,500 Added 48.48%
78,100 $7.13 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $2.39 Million - $2.73 Million
31,700 Added 151.67%
52,600 $5.06 Million
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $4.81 Million - $5.36 Million
-65,300 Reduced 75.75%
20,900 $1.79 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $5.77 Million - $6.67 Million
86,200 New
86,200 $7.43 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.